| Application no. and date | 19725627.4 (espacenet) (Federated) (European Patent Register), 20190510 | | Patent/reg. no. and date | DK/EP 3790877, 20230301 | | Publication date | 20210317 | | Priority no. and date | US 201862670249 P, 20180511, US 201862688164 P, 20180621 | | EP pub. no. and date |
EP 3790877 20210317 | | Effective date | | | Applicant/owner | Incyte Corporation, 1801 Augustine Cut-Off
Wilmington, DE 19803, US | | Applicant ref. no. | P81892DK01 | | Inventor | YAO, Wenqing, 1801 Augustine Cut-Off
Wilmington, Delaware 19803, US,
WU, Liangxing, 1801 Augustine Cut-Off
Wilmington, Delaware 19803, US,
XIAO, Kaijiong, 1801 Augustine Cut-Off
Wilmington, Delaware 19803, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/437 (2006.01) , A61P 35/00 (2006.01) , A61P 37/00 (2006.01) , C07D 471/04 (2006.01) | | Title | TETRAHYDRO-IMIDAZO[4,5-C]PYRIDINDERIVATER SOM PD-L1-IMMUNMODULATORER | | Int. application no. | US2019031728 | | Int. publication no. | WO2019217821 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
